InflaRx IFRX
NASDAQ IFRX
$1.23 -0.08 (-6.49%)
As of: Nov 10, 2026 · 2:59 PM EST

InflaRx (IFRX) Total Debt (2020 - 2026)

Updated

InflaRx's Total Debt came in at $6.02 million for Q1 2026, down 100.0% from the prior quarter.

Analysis

InflaRx (IFRX) Total Debt (2020 - 2026) Analysis & Trends

At the end of FY2025, InflaRx's Total Debt was $6.82 trillion.

  • Total Debt carries a five-year compound annual growth rate of 3324.1% (FY2020 to FY2025).
  • Going back by year, Total Debt was $156,519 in FY2021 (+8.1%).
  • The five-year range for quarterly Total Debt is $136,159 (Q2 2022) to $6.82 trillion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 44.65 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 80.90 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 32.35 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 26.23 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 62.67 Bn
10 InflaRx 85.79 Mn -160.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 6.02 Mn
Dec 31, 2025 6,815.93 Bn
Jun 30, 2025 5.34 Mn
Sep 30, 2022 140,824.11
Jun 30, 2022 136,158.78
Mar 31, 2022 146,624.10
Dec 31, 2021 156,518.68
Jun 30, 2021 148,752.68
Mar 31, 2021 419,959.43
Dec 31, 2020 144,802.99
API Access

InflaRx Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=IFRX&period=max&api_key=YOUR_API_KEY